Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001005286-25-000094
Filing Date
2025-07-17
Accepted
2025-07-17 18:48:53
Documents
1
Period of Report
2025-07-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1752792527.html 4  
1 FORM 4 wk-form4_1752792527.xml 4 3560
  Complete submission text file 0001005286-25-000094.txt   5031
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Issuer) CIK: 0001005286 (see all company filings)

EIN.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0525
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 450 SEVENTH AVENUE NEW YORK NY 10123
Business Address
OBUS NELSON (Reporting) CIK: 0001017043 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-27446 | Film No.: 251132032